rhBMP-6的表达、纯化与鉴定
|
摘要
第一部分rhBMP-6的表达、纯化与鉴定
骨形态发生蛋白(Bone morphogentic protein,BMP)属于TGF-β蛋白超家族(BMP-1缺乏碳段保守结构而除外)。BMP-6为BMP家族成员之一,与其它成员相比,BMP-6有较强的骨诱导作用。BMP-6在骨折愈合过程中表达上调,并在不同的骨缺损模型中,能加快缺损骨的修复。另外,系统给予BMP-6能有效治疗实验性骨质疏松引起的骨量减少和骨微观结构的改变,提示BMP-6对骨缺损和骨质疏松有潜在的治疗作用。本研究分别采用大肠杆菌和培养哺乳动物细胞为表达系统,通过基因工程途径获取具有生物活性的BMP-6蛋白。
1.BMP-6在大肠杆菌的表达、复性与纯化
以非融合形式分别在大肠杆菌胞质中表达不同截短模式,同时带有克隆位点引入氮端延伸序列(MA或MG)的BMP-6单体蛋白或BMP-6突变体(Ala~(56)-His)。表达菌株与表达条件筛选试验发现序列MA-BMP-6(1323)的表达量较高。因此选用MA-BMP-6(1323)在大肠杆菌BL-21(DE3)中表达BMP-6成熟肽单体蛋白。
诱导表达后,BMP-6约占菌体总蛋白的20%,以包涵体形式存在。包涵体分离纯化后,获得组成均一的BMP-6单体蛋白。溶解试验发现高浓度变性剂(6MGdn-HCl)合并还原剂(0.1M DTT)能有效溶解包涵体蛋白。经溶解、折叠、添加剂试验逐步筛选、优化复性条件后,约10%蛋白形成同源二聚体。BMP-6突变体对二聚体的形成没有显著影响。复性所得二聚体蛋白能够通过反相色谱纯化。可能由于缺乏糖基化缘故,纯化的二聚体蛋白碱性磷酸酶诱导活性的量效关系不显著。
2.BMP-6在CHO细胞中的表达、纯化与鉴定
将含BMP-6信号肽、前肽和成熟肽以及含BMP-2信号肽、前肽与BMP-6成熟肽融合的基因序列分别克隆至哺乳动物细胞表达载体。利用脂质体瞬时转染分析发现BMP2/6融合基因能有效分泌表达BMP-6蛋白。
然后采用二氢叶酸还原酶(Dihydroflolate reductase,DHFR)缺失的中华仓鼠卵巢细胞(Chinese hamster ovary cell,CHO)细胞为宿主,通过混合克隆、单克律秆∫约澳康幕蚶┰龊?获得表达水平约20 ng/10~6 cells/24 h的稳定表达细胞株。对稳定表达细胞株的比生长速率,BMP-6的比生成速率与分泌特性,以及BMP-6在培养环境与条件培养基中的稳定性进行了初步研究。条件培养基中的BMP-6通过肝素亲和色谱与反相色谱分离纯化,对纯化产物的纯度和生物活性进行了鉴定。
最后,纯化产物剂量和时间依赖地诱导碱性磷酸酶活性。与对照相比,BMP-6在浓度为25 ng/ml时活性显著,在400 ng/ml时达到最大反应剂量,而半数有效量介于100-150 ng/ml。用50 ng/ml的BMP-6处理细胞三天,碱性磷酸酶活性与对照相比差异显著。
结论:本研究采用大肠杆菌表达系统,以非融合包涵体形式表达BMP-6单体蛋白,通过优化表达、体外氧化复性和纯化获得成熟肽二聚体;同时采用CHO细胞分泌表达BMP-6,通过载体优化、细胞株筛选、纯化流程建立等途径获取具有显著生物活性的BMP-6蛋白。
第二部分BMP-6抗纤维化和氧化应激的作用与机制
除骨诱导作用外,BMP-6还参与机体发育和成体组织器官重塑过程的调节。研究发现慢性肾损伤时BMP-6表达下调,而慢性肾损伤直接抑制骨形成,提示抑制肾损伤可能能够促进骨形成。因此本文对BMP-6的抗肾纤维化以及抗氧化应激作用与机制进行研究。
1.BMP-6抑制TGF-β1诱导的PTEC转化
肾间质纤维化是慢性肾损伤的主要特征而TGF-β1在其中发挥重要作用。TGF-β1能诱导人近曲小管上皮细胞(Pmximal tubular epithelial cell,PTEC)HK-2细胞增殖抑制、上皮间质转化和黏附性增加,能诱导Fibtonectin和TIMP-2(Tissueinhibitors of metalloproteinase-2)表达,而抑制MMP-2(Matrix metalloproteinase 2)的表达和活性。同时,TGF-β1能激活Smad3和JNK激酶信号途径。BMP-6单独处理时,对HK-2细胞的增殖、形态表型、胞外基质蛋白的合成以及黏附性无明显影响。但是BMP-6能抑制TGF-β1诱导HK-2细胞增殖抑制,形态、表型转化,胞外基质蛋白的堆积以及黏附性增加,同时能抑制TGF-β1诱导的Smad3和JNK激酶的激活。本文研究证实BMP-6能抑制TGF-β1诱导的纤维化作用,这种作用可能是通过抑制JNK激酶和Smad3信号途径的活化而实现。
2.BMP-6通过Smad5途径诱导HO-1表达而抗PTEC氧化应激损伤
研究发现氧自由基参与TGF-β1诱导的PTEC转化而血红素氧合酶1(hemeoxygenase 1,HO-1)是机体抗氧化应激的重要机制。BMP-6能剂量和时间依赖地抑制双氧水诱导的HK-2细胞氧化应激损伤,以及诱导HO-1表达。HO-1诱导、过表达以及HO-1产物胆红素或一氧化碳能减轻HK-2细胞的氧化应激损伤,而新基因合成抑制、HO-1活性抑制、HO-1基因干扰或一氧化碳捕获等能减弱BMP-6的抗氧化应激作用。BMP-6能激活Smad5途径,而Smad5基因干扰则抑制HO-1的诱导表达。HO-1启动子上Smad5结合位点缺失或突变能抑制BMP-6诱导的HO-1启动子活性增加。最终证实BMP-6通过Smad5途径诱导HO-1表达,通过HO-1的产物胆红素和一氧化碳来发挥抗氧化应激损伤作用。
结论:本研究在培养的肾近曲小管上皮细胞中发现,BMP-6能抑制TGF-β1诱导的肾近曲小管上皮细胞纤维化转变,并且能通过激活Smad5信号途径诱导HO-1表达而减轻肾近曲小管上皮细胞氧化应激损伤。这一结果为进一步深入研究BMP-6的骨生成和肾保护作用、机制与应用奠定了基础。
PartⅠExpression,purification,and characterization of rhBMP-6
Bone morphogenetic proteins(BMPs) belong to the transformation growth factorsβsuperfamily(TGF-β) except BMP-1,which lack the C-terminal conserve domain of TGF-β.BMP-6 is one member of BMPs family and is one of the most potent osteogenesis factors as compared with the other members of BMP family.BMP-6 is induced in different stages of bone fracture.BMP-6 promotes bone regeneration in different bone deficiency model.In addition,BMP-6 administered systematically, restores bone volume and micro-architecture in osteoporotic rat and mouse.These results indicate BMP-6 as a therapeutic potential candidate for treating bone deficiency and osteoporosis.In the present study,we recombinant produced BMP-6 in Escherichia coli and cultivated mammalian cells.
1.Expression,refolding,and purification of BMP-6 in E.Coli
The variants of BMP-6 and BMP-6 mutant(Ala~(56)-His) plus an N-terminal extension(MA or MG duo to the clone site) were expressed in E.Coli as non-fusion protein,respectively.The expression level of the mature peptide with MA extension (MA-BMP-6(1323)) was significantly higher than the other's by screening of host cells and expression constructs under different growth conditions.This construct was transformed into an E.coli BL21(DE3) for the expression of BMP-6 mature peptide.
BMP-6 was expressed as IBs after induction,contributing up to 20%of the total bacterial protein.Protein was near homogenous after a simplified procedure of IBs isolation.The IBs were dissolved in 6M Gdn-HCl and 0.1M DTT containing buffer. The refolded dimeric protein was obtained by dilution the dissolved IBs protein in an optimized refolding buffer and about 10%of BMP-6 formed disulphide-linked homodimers.This buffer system was optimized step by step,including solubility, refolding,and refolding adding agent determined.BMP-6 mutant could not improve efficiency of refolding.The refolded dimeric BMP-6 was purified by one step reverse phase liquid chromatography.Howerver,the dose-dependent alkaline phosphatase (ALP) induction activity of the purified dimeric protein was not observed,probably due to lack of N-glycosylation produced in E.Coli.
2.Expression,purification,and characterization of BMP-6 in CHO cells
The prepromature peptide of BMP-6 and prepro-peptide of BMP-2 fused with mature peptide of BMP6(BMP2/6) was subcloned into the mammalian expression vector,respectively.The BMP2/6 construction could efficiently pruduce BMP-6 protein after transient transfection in Cos 7 via liposame reagent.
BMP-6 was stable epressed in dihydroflolate reductase deficiency Chinese hamster ovary(CHO-dhfr-) cells.BMP-6 expression levels of the most productive subclones was about 20 ng/10~6 cells/24 h after individual and cell pool based selection followed by target gene amplification.The specific growth rate,BMP-6 production, and stability of BMP-6 in culture condition and conditioned medium were characterized.BMP-6 was purified by combination of heparin affinity and reverse phase chromatography.The purified product was indentified by SDS-PAGE and western blot.
Finally,the purified BMP-6 induced alkaline phophatase(ALP) activity in a time-course and dose-dependent manner.The ALP activity was significantly induced at concentration of 25ng/ml.EC50 was about 100-150ng/ml and the maximal effective dose was about 400ng/ml.The ALP activity was significantly induced after 3 days incubation at concentration of 50ng/ml.
In summary,the non-fusion human BMP-6 was expressed in E.coli as IBs with high level.After the optimized procedure for IBs isolation and refolding,the refolded dimeric protein was purified by one step reverse phase liquid chromatography. Furthermore,the BMP-6 was expressed in CHO cells.After vector construction, stable cell line screening,and purification scheme optimazation,the bioactive BMP-6 protein was produced.
PartⅡEffect and mechanism of BMP-6 on fibrosis and oxidant stress
BMP-6 plays a role during embryonal development and tissue morphogenesis postnatal as well as bone formation.Downregulation of BMP-6 may predispose to renal deficiency and chronic renal deficiency directly reduced bone formation, indicating that suppression of chronic renal deficiency my improve bone regeneration. In the present study,the effect and mechamism of BMP-6 on renal fibrosis and oxidant injury were investigated.
1.BMP-6 reverses TGF-β1-initiated changes of PTEC
Transforming growth factor-beta 1(TGF-β1) plays a crucial role in the inception and progression of renal tubulointerstitial fibrosis which lead to renal deficiency. Treatment with TGF-β1 reduced cell proliferation,induced epithelial-to-mesenchymal transition(EMT),deceased expression and activity of matrix metalloproteinases 2(MMP-2),increased expression of fibronectin and tissue inhibitors of matrix metalloproteinases 2(TIMP-2),and increased cell adhesion in renal proximal tubular epithelial cell(PTEC) HK-2 cells.All these effects were inhibited when TGF-β1 was combined with BMP-6,whereas BMP-6 alone had no such effects.In addition,BMP-6 abrogated the JNK and Smad3 signaling activated by TGF-β1.BMP6 ameliorated TGF-β1 induced fibrosis changes in HK-2 cells and suppression of TGF-β1-mediated JNK and Smad3 activation maybe implicated.
2.BMP-6 attenuates oxidant injury in PTEC via Smad-dependent HO-1 induction
Reactive oxygen species are involved in TGF-β1-induced transition and heme oxygenase 1(HO-1) induction is a protective response to oxidative stress.BMP-6 effectively protected renal proximal tubule cells(HK-2) against hydrogen peroxide (H_2O_2)-induced cell injury.BMP-6 also increased HO-1 gene expression.Inhibition of de novo gene expression,HO-1 inhibitor,HO-1 knockdown,or carbon monoxide (CO) scavenger attenuated the cytoprotective effect of BMP-6,whereas HO-1 inducer, HO-1 constitutive expression,or HO-1 products bilirubin and CO ameliorated H_2O_2-induced cell injury.Stimulation of HK-2 cells with BMP-6 activated Smad5 signaling and BMP6-mediated induction of HO-1 expression was inhibited by Smad5 knockdown.Furthermore,deletion or mutation of the Smad-binding element in HO-1 promoter inhibited the BMP-6-induced HO-1 promoter activity.These findings suggest that induction of HO-1 through a Smad-dependent manner is responsible for the cytoprotective effect of BMP-6 in H_2O_2-mediated renal cell injury.
In summery,the antifibrotic and antioxidant effect of BMP-6 were determined in renal proximal tubular epithelial cells,useful for further therapeutic investigations of BMP-6 in the treatment of renal interstitial fibrosis and bone deficiency.
骨形态发生蛋白(Bone morphogentic protein,BMP)属于TGF-β蛋白超家族(BMP-1缺乏碳段保守结构而除外)。BMP-6为BMP家族成员之一,与其它成员相比,BMP-6有较强的骨诱导作用。BMP-6在骨折愈合过程中表达上调,并在不同的骨缺损模型中,能加快缺损骨的修复。另外,系统给予BMP-6能有效治疗实验性骨质疏松引起的骨量减少和骨微观结构的改变,提示BMP-6对骨缺损和骨质疏松有潜在的治疗作用。本研究分别采用大肠杆菌和培养哺乳动物细胞为表达系统,通过基因工程途径获取具有生物活性的BMP-6蛋白。
1.BMP-6在大肠杆菌的表达、复性与纯化
以非融合形式分别在大肠杆菌胞质中表达不同截短模式,同时带有克隆位点引入氮端延伸序列(MA或MG)的BMP-6单体蛋白或BMP-6突变体(Ala~(56)-His)。表达菌株与表达条件筛选试验发现序列MA-BMP-6(1323)的表达量较高。因此选用MA-BMP-6(1323)在大肠杆菌BL-21(DE3)中表达BMP-6成熟肽单体蛋白。
诱导表达后,BMP-6约占菌体总蛋白的20%,以包涵体形式存在。包涵体分离纯化后,获得组成均一的BMP-6单体蛋白。溶解试验发现高浓度变性剂(6MGdn-HCl)合并还原剂(0.1M DTT)能有效溶解包涵体蛋白。经溶解、折叠、添加剂试验逐步筛选、优化复性条件后,约10%蛋白形成同源二聚体。BMP-6突变体对二聚体的形成没有显著影响。复性所得二聚体蛋白能够通过反相色谱纯化。可能由于缺乏糖基化缘故,纯化的二聚体蛋白碱性磷酸酶诱导活性的量效关系不显著。
2.BMP-6在CHO细胞中的表达、纯化与鉴定
将含BMP-6信号肽、前肽和成熟肽以及含BMP-2信号肽、前肽与BMP-6成熟肽融合的基因序列分别克隆至哺乳动物细胞表达载体。利用脂质体瞬时转染分析发现BMP2/6融合基因能有效分泌表达BMP-6蛋白。
然后采用二氢叶酸还原酶(Dihydroflolate reductase,DHFR)缺失的中华仓鼠卵巢细胞(Chinese hamster ovary cell,CHO)细胞为宿主,通过混合克隆、单克律秆∫约澳康幕蚶┰龊?获得表达水平约20 ng/10~6 cells/24 h的稳定表达细胞株。对稳定表达细胞株的比生长速率,BMP-6的比生成速率与分泌特性,以及BMP-6在培养环境与条件培养基中的稳定性进行了初步研究。条件培养基中的BMP-6通过肝素亲和色谱与反相色谱分离纯化,对纯化产物的纯度和生物活性进行了鉴定。
最后,纯化产物剂量和时间依赖地诱导碱性磷酸酶活性。与对照相比,BMP-6在浓度为25 ng/ml时活性显著,在400 ng/ml时达到最大反应剂量,而半数有效量介于100-150 ng/ml。用50 ng/ml的BMP-6处理细胞三天,碱性磷酸酶活性与对照相比差异显著。
结论:本研究采用大肠杆菌表达系统,以非融合包涵体形式表达BMP-6单体蛋白,通过优化表达、体外氧化复性和纯化获得成熟肽二聚体;同时采用CHO细胞分泌表达BMP-6,通过载体优化、细胞株筛选、纯化流程建立等途径获取具有显著生物活性的BMP-6蛋白。
第二部分BMP-6抗纤维化和氧化应激的作用与机制
除骨诱导作用外,BMP-6还参与机体发育和成体组织器官重塑过程的调节。研究发现慢性肾损伤时BMP-6表达下调,而慢性肾损伤直接抑制骨形成,提示抑制肾损伤可能能够促进骨形成。因此本文对BMP-6的抗肾纤维化以及抗氧化应激作用与机制进行研究。
1.BMP-6抑制TGF-β1诱导的PTEC转化
肾间质纤维化是慢性肾损伤的主要特征而TGF-β1在其中发挥重要作用。TGF-β1能诱导人近曲小管上皮细胞(Pmximal tubular epithelial cell,PTEC)HK-2细胞增殖抑制、上皮间质转化和黏附性增加,能诱导Fibtonectin和TIMP-2(Tissueinhibitors of metalloproteinase-2)表达,而抑制MMP-2(Matrix metalloproteinase 2)的表达和活性。同时,TGF-β1能激活Smad3和JNK激酶信号途径。BMP-6单独处理时,对HK-2细胞的增殖、形态表型、胞外基质蛋白的合成以及黏附性无明显影响。但是BMP-6能抑制TGF-β1诱导HK-2细胞增殖抑制,形态、表型转化,胞外基质蛋白的堆积以及黏附性增加,同时能抑制TGF-β1诱导的Smad3和JNK激酶的激活。本文研究证实BMP-6能抑制TGF-β1诱导的纤维化作用,这种作用可能是通过抑制JNK激酶和Smad3信号途径的活化而实现。
2.BMP-6通过Smad5途径诱导HO-1表达而抗PTEC氧化应激损伤
研究发现氧自由基参与TGF-β1诱导的PTEC转化而血红素氧合酶1(hemeoxygenase 1,HO-1)是机体抗氧化应激的重要机制。BMP-6能剂量和时间依赖地抑制双氧水诱导的HK-2细胞氧化应激损伤,以及诱导HO-1表达。HO-1诱导、过表达以及HO-1产物胆红素或一氧化碳能减轻HK-2细胞的氧化应激损伤,而新基因合成抑制、HO-1活性抑制、HO-1基因干扰或一氧化碳捕获等能减弱BMP-6的抗氧化应激作用。BMP-6能激活Smad5途径,而Smad5基因干扰则抑制HO-1的诱导表达。HO-1启动子上Smad5结合位点缺失或突变能抑制BMP-6诱导的HO-1启动子活性增加。最终证实BMP-6通过Smad5途径诱导HO-1表达,通过HO-1的产物胆红素和一氧化碳来发挥抗氧化应激损伤作用。
结论:本研究在培养的肾近曲小管上皮细胞中发现,BMP-6能抑制TGF-β1诱导的肾近曲小管上皮细胞纤维化转变,并且能通过激活Smad5信号途径诱导HO-1表达而减轻肾近曲小管上皮细胞氧化应激损伤。这一结果为进一步深入研究BMP-6的骨生成和肾保护作用、机制与应用奠定了基础。
PartⅠExpression,purification,and characterization of rhBMP-6
Bone morphogenetic proteins(BMPs) belong to the transformation growth factorsβsuperfamily(TGF-β) except BMP-1,which lack the C-terminal conserve domain of TGF-β.BMP-6 is one member of BMPs family and is one of the most potent osteogenesis factors as compared with the other members of BMP family.BMP-6 is induced in different stages of bone fracture.BMP-6 promotes bone regeneration in different bone deficiency model.In addition,BMP-6 administered systematically, restores bone volume and micro-architecture in osteoporotic rat and mouse.These results indicate BMP-6 as a therapeutic potential candidate for treating bone deficiency and osteoporosis.In the present study,we recombinant produced BMP-6 in Escherichia coli and cultivated mammalian cells.
1.Expression,refolding,and purification of BMP-6 in E.Coli
The variants of BMP-6 and BMP-6 mutant(Ala~(56)-His) plus an N-terminal extension(MA or MG duo to the clone site) were expressed in E.Coli as non-fusion protein,respectively.The expression level of the mature peptide with MA extension (MA-BMP-6(1323)) was significantly higher than the other's by screening of host cells and expression constructs under different growth conditions.This construct was transformed into an E.coli BL21(DE3) for the expression of BMP-6 mature peptide.
BMP-6 was expressed as IBs after induction,contributing up to 20%of the total bacterial protein.Protein was near homogenous after a simplified procedure of IBs isolation.The IBs were dissolved in 6M Gdn-HCl and 0.1M DTT containing buffer. The refolded dimeric protein was obtained by dilution the dissolved IBs protein in an optimized refolding buffer and about 10%of BMP-6 formed disulphide-linked homodimers.This buffer system was optimized step by step,including solubility, refolding,and refolding adding agent determined.BMP-6 mutant could not improve efficiency of refolding.The refolded dimeric BMP-6 was purified by one step reverse phase liquid chromatography.Howerver,the dose-dependent alkaline phosphatase (ALP) induction activity of the purified dimeric protein was not observed,probably due to lack of N-glycosylation produced in E.Coli.
2.Expression,purification,and characterization of BMP-6 in CHO cells
The prepromature peptide of BMP-6 and prepro-peptide of BMP-2 fused with mature peptide of BMP6(BMP2/6) was subcloned into the mammalian expression vector,respectively.The BMP2/6 construction could efficiently pruduce BMP-6 protein after transient transfection in Cos 7 via liposame reagent.
BMP-6 was stable epressed in dihydroflolate reductase deficiency Chinese hamster ovary(CHO-dhfr-) cells.BMP-6 expression levels of the most productive subclones was about 20 ng/10~6 cells/24 h after individual and cell pool based selection followed by target gene amplification.The specific growth rate,BMP-6 production, and stability of BMP-6 in culture condition and conditioned medium were characterized.BMP-6 was purified by combination of heparin affinity and reverse phase chromatography.The purified product was indentified by SDS-PAGE and western blot.
Finally,the purified BMP-6 induced alkaline phophatase(ALP) activity in a time-course and dose-dependent manner.The ALP activity was significantly induced at concentration of 25ng/ml.EC50 was about 100-150ng/ml and the maximal effective dose was about 400ng/ml.The ALP activity was significantly induced after 3 days incubation at concentration of 50ng/ml.
In summary,the non-fusion human BMP-6 was expressed in E.coli as IBs with high level.After the optimized procedure for IBs isolation and refolding,the refolded dimeric protein was purified by one step reverse phase liquid chromatography. Furthermore,the BMP-6 was expressed in CHO cells.After vector construction, stable cell line screening,and purification scheme optimazation,the bioactive BMP-6 protein was produced.
PartⅡEffect and mechanism of BMP-6 on fibrosis and oxidant stress
BMP-6 plays a role during embryonal development and tissue morphogenesis postnatal as well as bone formation.Downregulation of BMP-6 may predispose to renal deficiency and chronic renal deficiency directly reduced bone formation, indicating that suppression of chronic renal deficiency my improve bone regeneration. In the present study,the effect and mechamism of BMP-6 on renal fibrosis and oxidant injury were investigated.
1.BMP-6 reverses TGF-β1-initiated changes of PTEC
Transforming growth factor-beta 1(TGF-β1) plays a crucial role in the inception and progression of renal tubulointerstitial fibrosis which lead to renal deficiency. Treatment with TGF-β1 reduced cell proliferation,induced epithelial-to-mesenchymal transition(EMT),deceased expression and activity of matrix metalloproteinases 2(MMP-2),increased expression of fibronectin and tissue inhibitors of matrix metalloproteinases 2(TIMP-2),and increased cell adhesion in renal proximal tubular epithelial cell(PTEC) HK-2 cells.All these effects were inhibited when TGF-β1 was combined with BMP-6,whereas BMP-6 alone had no such effects.In addition,BMP-6 abrogated the JNK and Smad3 signaling activated by TGF-β1.BMP6 ameliorated TGF-β1 induced fibrosis changes in HK-2 cells and suppression of TGF-β1-mediated JNK and Smad3 activation maybe implicated.
2.BMP-6 attenuates oxidant injury in PTEC via Smad-dependent HO-1 induction
Reactive oxygen species are involved in TGF-β1-induced transition and heme oxygenase 1(HO-1) induction is a protective response to oxidative stress.BMP-6 effectively protected renal proximal tubule cells(HK-2) against hydrogen peroxide (H_2O_2)-induced cell injury.BMP-6 also increased HO-1 gene expression.Inhibition of de novo gene expression,HO-1 inhibitor,HO-1 knockdown,or carbon monoxide (CO) scavenger attenuated the cytoprotective effect of BMP-6,whereas HO-1 inducer, HO-1 constitutive expression,or HO-1 products bilirubin and CO ameliorated H_2O_2-induced cell injury.Stimulation of HK-2 cells with BMP-6 activated Smad5 signaling and BMP6-mediated induction of HO-1 expression was inhibited by Smad5 knockdown.Furthermore,deletion or mutation of the Smad-binding element in HO-1 promoter inhibited the BMP-6-induced HO-1 promoter activity.These findings suggest that induction of HO-1 through a Smad-dependent manner is responsible for the cytoprotective effect of BMP-6 in H_2O_2-mediated renal cell injury.
In summery,the antifibrotic and antioxidant effect of BMP-6 were determined in renal proximal tubular epithelial cells,useful for further therapeutic investigations of BMP-6 in the treatment of renal interstitial fibrosis and bone deficiency.
引文
[1] Kronenberg HM. Developmental regulation of the growth plate. Nature, 2003, 423:332-336
[2] Senn, N. On the healing of aseptic bone cavities by implantation of antiseptic decalcified one. Am J Med Sci, 1889, 98:219-240
[3] Dimitriou R, Giannoudis PV. Discovery and development of BMPs. Injury, 2005, 36 Suppl 3:S28-33
[4] Lacroix P. Recent investigations on the growth of bone. Nature, 1945,156:576
[5] Sharrard WJ, Collins DH. The fate of human decalcified bone grafts. Proc Roy Soc Med, 1961,54:1101-1102
[6] Urist MR. Bone: formation by autoinduction. Science, 1965,150: 893-899
[7] Sampath TK, Reddi AH. Dissociative extraction and reconstitution of bone matrix components involved in local bone differentiation. Proc Natl Acad Sci USA, 1981, 78:7599-7603
[8] Sampath TK, Coughlin JE, Whetstone RM, et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem, 1990,265:13198-13205
[9] Johnson EE, Urist MR, Finerman GA. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin Orthop, 1992, 277:229-237
[10] Wozney JM, V. Rosen AJ, Celeste LM et al. Novel regulators of bone formation: molecular clones and activities. Science, 1988,242:1528-1534
[11] Celeste AJ, Iannazzi JA, Taylor RC. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA, 1990, 87:9843-9847
[12] Urist MR, Iwata H, Ceccotti PL, et al. Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci USA, 1973, 70:3511-3515
[13] Urist MR, Huo YK, Brownell AG, et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci USA, 1984, 81:371 -37
[14] Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA, 1988, 85:9484-9488
[15] Luyten F, Cunningham NS, Ma S. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem, 1989,265:13377-13380
[16] Ozkaynak EDC, Rueger EA, Drier C et al. OP-1 cDNA encodes an osteogenic protein in the TGF-β family.EMBO J,1990,9:2085-2093
[17]Wang EA,Rosen V,D'Alessandro JS et al.Recombinant human bone morphogenetic protein induces bone formation.Proc Natl Acad Sci,1990,87:2220-2224
[18]Hammonds RG,Schwall R,Dudley A.Bone-inducing activity of mature BMP-2B produced from a hybrid BMP-2A/2B precursor.Mol Endocrinol,1991,5:149-155
[19]K(u|¨)bler N.Herstellung und Biologic der bone morphogenetic proteins.Biomaterialien,2000,1:12-18
[20]Maruoka Y,Oida S,Iimura T et al.Production of functional human bone morphogenetic protein-2 using a baculovirus/Sf-9 insect cell system.Biochem Mol Biol Int,1995,35:957-963
[21]Hazama M,Aono A,Ueno N et al.Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system.Biochem Biophys Res Commun,1995,209:859-866
[22]Kubler NR,Reuther JF,Failer G et al.Inductive properties of recombinant human BMP-2produced in a bacterial expression system.Int J Oral Maxillofac Surg,1998,27:305-309
[23]Ruppert R,Hoffmann E,Sebald W.Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.Eur J Biochem,1996,237:295-302
[24]Vallejo LF,Brokelmann M,Marten S et al.Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.J Biotechnol,2002,94:185-194
[25]Vallejo LF,Rinas U.Optimized procedure for renaturation of recombinant human bone morphogenetic protein 2 at high concentration.Biotech Bioeng,2004,85:601-609
[26]Ten Dijke P,Yamashita H,Sampath TK,er al.Identification of type Ⅰ receptors for osteogenic protein-1 and bone morphogenetic protein-4.J Biol Chem,1994,269:16985-16988
[27]Rosenzweig BL,Imamura T,Okadome T,et al.Cloning and characterization of a human type Ⅱ receptor for bone morphogenetic proteins.Proc Natl Acad Sci USA,1995,92:7632-7636
[28]Lavery K,Swain P,Falb D,et al.BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.J Biol Chem.2008 Jul 25;283(30):20948-58
[29]Miyazono K,Maeda S,Imamura T.BMP receptor signaling:Transcriptional targets,regulation of signals,and signaling cross-talk.Cytokine & Growth Factor Reviews,2005,16:251-263
[30]Zhang H,Bradley A.Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development.Development,1996,122:2977-2986
[31]Daluiski A,Engstrand T,Bahamonde ME,et al.Bone morphogenetic protein-3 is a negative regulator of bone density.Nat Genet,2001,27:84-88
[32]Winnier G,Blessing M,Labosky PA,et al.Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.Genes Dev,1995,9:2105-2116
[33]Lawson KA,Dunn NR,Roelen BA,et al.Bmp4 is required for the generation of primordial germ cells in the mouse embryo.Genes Dev,1999,13:424-436
[34]Kingsley DM,Bland AE,Grubber JM,et al.The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily.Cell,1992,71:399-410
[35]Solloway MJ,Dudley AT,Bikoff EK,et al.Mice lacking Bmp6 function.Dev Genet,1998,22:321-339
[36]Luo G,Hofmann C,Bronckers AL,et al.BMP-7 is an inducer of nephrogenesis,and is also required for eye development and skeletal patterning.Genes Dev,1995,9:2808-2820
[37]Zhao GQ,Liaw L,Hogan BL.Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis.Development,1998,125:1103-1112
[38]Zhao GQ,Deng K,Labosky PA,et al.The gene encoding bone morphogenetic protein 8B (BMP8B) is required for the initiation and maintenance of spermatogenesis in the mouse.Genes Dev,1996,10:1657-1669
[39]McPherron AC,Lawler AM,Lee SJ.Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11.Nat Genet,1999,22:260-264
[40]Maloul A,Rossmeier K,Mikic B,et al.Geometric and material contributions to whole bone structural behavior in GDF-7-deficient mice.Connect Tissue Res,2006,47:157-162
[41]Yan C,Wang P,DeMayo J,et al.Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.Mol Endocrinol,2001,15:854-866
[42]Storm EE,Huynh TV,Copeland NG,et al.Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily.Nature,1994,368:639-643
[43]McPherron AC,Lawler AM,Lee SJ.Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.Nature,1997,387:83-90
[44]Dong J,Albertini DF,Nishimori K,et al.Growth differentiation factor-9 is required during early ovarian folliculogenesis.Nature,1996,383:531-535
[45]Ying Y,Zhao GQ.Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse.Dev Biol,2001,232:484-492
[46]Kugimiya F,Kawaguchi H,Kamekura S,et al.Involvement of endogenous bone morphogenetic protein 2 and 6 in bone formation.J Biol Chem,2005,280:35704-35711
[47]Katagiri T,Boorla S,Frendo JL,et al.Skeletal abnormalities in doubly heterozygous Bmp4and Bmp7 mice.Dev Genet,1998,22:340-348
[48]Solloway MJ,Robertson EJ.Early embryonic lethality in Bmp5/Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup.Development,1999,126:1753-1768
[49]Storm EE,Kingsley DM.Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein(BMP) family Development,1996,122:3969-3979
[50]Kim RY,Robertson EJ,Solloway MJ.Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart.Dev Biol,2001,235:449-466
[51]Zhao GQ,Chen YX,Liu XM,et al.Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis.Dev Biol,2001,240:212-222
[52]Ying Y,Liu XM,Marble A,et al.Requirement of Bmp8b for the Generation of Primordial Germ Cells in the Mouse.Mol.Endocrinol,2000,14:1053-1063
[53]Chen TL,Bates RL,Dudley A,et al.Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells:comparison with TGF-beta 1.J Bone Miner Res,1991,6:1387-1393
[54]Vukicevic S,Luyten FP,Reddi AH.Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin.Proc Natl Acad Sci USA,1989,86:8793-8797
[55]Chen P,Carrington JL,Hammonds RG,et al.Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B(BMP-2B) and modulation by transforming growth factor beta 1 and beta 2.Exp Cell Res,1991,195:509-515
[56]Thies RS,Bauduy M,Ashton BA,et al.Recombinant human bone morphogenetic protein-2induces osteoblastic differentiation in W-20-17 stromal cells.Endocrinology,1992,130:1318-1324
[57]Wan M,Cao X.BMP signaling in skeletal development.Biochem Biophys Res Commun,2005,328:651-657
[58]Einhorn TA,Majeska RJ,Mohaideen A,et al.A single percutaneons injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair.J Bone Joint Surg Am,2003,85A:1425-1435
[59]Cook SD,Dalton JE,Tan EH,et al.In vivo evaluation of recombinant human osteogenic protein(rhOP-1) implants as a bone graft substitute for spinal fusions.Spine,1994,19:1655-1663
[60]Cook SD,Baffes G-C,Wolfe MW,et al.The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects.J Bone Joint Surg Am,1994,76:827-838
[61]Higuchi T,Kinoshita A,Takahashi K,et al.Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects.An experimental model of defect filling.J Periodontol,1999,70:1026-1031
[62]Cook SD,Patron LP,Salkeld SL,et al.Repair of articular cartilage defects with osteogenic protein-1(BMP-7) in dogs.J Bone Joint Surg Am,2003,85A(S3):116-123
[63]Simank HG,Manggold J,Sebald W,et al.Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model.Growth Factors,2001,19:247-257.
[64]Wikesjo UM,Guglielmoni P,Promsudthi A,et al.Periodontal repair in dogs:effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment.J Clin Periodontol,1999,26:392-400
[65]Termaat MF,Den Boer FC,Bakker FC,et al.Bone morphogenetic proteins.Development and clinical efficacy in the treatment of fractures and bone defects.J Bone Joint Surg Am,2005,87:1367-1378
[66]Okubo Y,Bessho K,Fujimura K.et al.The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector.Life Sci,2001,70:325-336
[67]Groeneveld EHJ,Burger EH.Bone morphogenetic proteins in human bone regeneration.Eur J Endocrinol,2000,142:9-21
[68]Govender S,Csimma C,Genant HK,et al.BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group.Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures:a prospective,controlled,randomized study of four hundred and fifty patients.J Bone Joint Surg Am,2002,84A:2123-2134
[69]Geesink RGT,Hoefnagels NHM,Bulstra SK.Osteogenic activity of OP-1 bone morphogenetic protein(BMP-7) in a human fibular defect.J Bone Joint Surg Br,1999,81B:710-718
[70]Friedlaender GE,Perry CR,Cole JD,et al.Osteogenic protein-1(bone morphogenetic protein-7) in the treatment of tibial nonunions.J Bone Joint Surg Am,2001,83(S1):151-158
[71]Boden SD,Kang J,Sandhu H,et al.Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans:a prospective,randomized clinical pilot trial:2002 Volvo Award in clinical studies.Spine,2002,27:2662-2673
[72]Johnsson R,Stromqvist B,Aspenberg P.Randomized radiostereometric study comparing osteogenic protein-1(BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion:2002 Volvo Award in clinical studies.Spine,2002,27:2654-2661
[73]Zlotolow DA,Vaccaro AR,Salamon ML,et al.The role of human bone morphogenetic proteins in spinal fusion.J Am Acad Orthop Surg,2000,8:3-9
[74]Neuhaus H,Rosen V,Thies RS.Heart specific expression of mouse BMP-10 a novel member of the TGF-beta superfamily.Mech.Dev,1999,80:181-184
[75]Jiao K,Kulessa H,Tompkins K An essential role of Bmp4 in the atrioventricular septation of the mouse heart.Genes Dev.2003,17:2362-2367
[76]Behfar A,Zingman LV,Hodgson DM,et al.Stem cell differentiation requires a paracrine pathway in the heart.FASEB J,2002,16:1558-1566
[77]Sharma M,Kambadur R,Matthews KG,et al.Myostatin,a transforming growth factor-beta superfamily member,is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.J Cell Physiol,1999,180:1-9
[78]Kempf T,Eden M,Strelau J,et al.The transforming growth factor-{beta} superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.Circ.Res.2006,98:351-360
[79]Humbert M,Trembath RC.Genetics of pulmonary hypertension:from bench to bedside.Eur Respir J,2002,20:741-749
[80]Cheng SL,Shao JS,Charlton-Kachigian N,et al.MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors.J Biol Chem,2003,278:45969-45977
[81]Swear A,Sane DC,Hutson SM,et al.Matrix Gla protein(MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats.J Thromb Haemost,2003,1:178-185
[82]Sorescu GP,Sykes M,Weiss D,et al.Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response.J Biol Chem,2003,278:31128-31135
[83]Davies MR,Lund RJ,Hruska KA.BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure.J Am Soc Nephrol,2003,14:1559-1567
[84]Chang CF,Lin SZ,Chiang YH,et al.Intravenous administration of bone morpbogenetic protein-7 after ischemia improves motor function in stroke rats.Stroke,2003,34:558-564
[85]Wang Y,Chang CF,Morales M,et al.Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats.Stroke,2001,32:2170-2178
[86]Dudley AT,Lyons KM,Robertson EJ.A requirement for bone morphogenetic protein-7during development of the mammalian kidney and eye.Genes Dev,1995,9:2795-2807
[87]Simic P,Vukicevic S.Bone morphogenetic proteins in development and homeostasis of kidney.Cytokine Growth Factor Rev.2005,16:299-308
[88]Zeisberg M,Hanai J,Sugimoto H,et al.BMP-7 counteracts TGF-betal-induced epithelial-tomesenchymal transition and reverses chronic renal injury.Nat Med,2003,9:964-968
[89]Miller AF,Harvey SA,Thies RS,et al.Bone morphogenetic protein-9.An autocrine/paracrine cytokine in the liver.J Biol Chem,2000,275:17937-17945
[90]Wang W,Yang Y,Meng Y,et al.GDF-3 is an adipogenic cytokine under high fat dietary condition.Biochem Biophys Res Commun,2004,321:1024-1031
[91]De Bosscher K,Hill CS,Nicolas FJ.Molecular and functional consequences of Smad4C-terminal missense mutations in colorectal tumour cells.Biochem J,2004,379:209-216
[92]Hanavadi S,Martin TA,Watkins G,et al.The role of growth differentiation factor-9(GDF-9)and its analog,GDF-gb/BMP-15,in human breast cancer.Ann Surg Oncol,2007,14:2159-2166
[93]Alarmo EL,Kuukasj(a|¨)rvi T,Karhu R,et al.comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.Breast Cancer Res Treat,2007,103:239-246
[94]Schwalbe M,S(a|¨)ger J,Eggers R,et al.Differential expression and regulation of bone morphogenetic protein 7 in breast cancer.Int J Oncol,2003,23:89-95
[95]Buijs JT,Henriquez NV,van Overveld PG,et al.Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.Cancer Res,2007,67:8742-8751
[96]Alarmo EL,Korhonen T,Kuukasj(a|¨)rvi T,et al.Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.Ann Oncol,2008,19:308-314
[97]Lyons K,Graycar JL,Lee A,et al.Vgr-1,a mammalian gene related to Xenopus Vg-1,is a member of the transforming growth factor beta gene superfamily.Proc Natl Acad Sci USA,1989,86:4554-4558
[98]Ebisawa T,Tada K,Kitajima I,et al.Characterization of bone morphogenetic protein-6signaling pathways in osteoblast differentiation.J Cell Sci,1999,112:3519-3527.
[99]Sivertsen EA,Huse K,Hystad ME,et al.Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.Eur J Immunol,2007,37:2937-2948
[100]Grimsrud CD,Romano PR,D'Souza M,et al.BMP-6 is an autocrine stimulator of chondrocyte differentiation.J Bone Miner Res,1999,14:475-482
[101]Boskey AL,Paschalis EP,Binderman I.BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures.J Cell Biochem,2002,84:509-519
[102]Kang Q,Sun MH,Cheng H,et al.Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery.Gene Ther,200411:1312-1320
[103]Li JZ,Li H,Sasaki T,et al.Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.Gene Ther,2003,10:1735-1743
[104]Cheng H,Jiang W,Phillips FM,et al.Osteogenic activity of the 14 types of human bone morphogenetic proteins(BMPs).J Bone Joint Surgery Am,2003,85:1544-1552
[105]Luu HH,Song WX,Luo X,et al.Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells.J Orthop Res,2007,25:665-677
[106]Peng Y,Kang Q,Cheng H,et al.Transcriptional characterization of bone morphogenetic proteins(BMPs)-mediated osteogenic signaling.J Cell Biochem,2003,90:1149-1165
[107]Zachos TA,Shields KM,Bertone AL.Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or-6.J Orthop Res,2006,24:1279-1291
[108]Friedman MS,Long MW,Hankenson KD.Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6.J Cell Biochem,2006,98:538-554
[109]Wutzl A,Brozek W,Lernbass I,et al.Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.J Biomed Mater Res A,2006,77:75-83
[110]Valdes M,Moore DC,Palumbo M,et al.rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.Spine J,2007,7:318-325
[111]Laurent JJ,Webb KM,Beres EJ,et al.The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits.J Neurosurg Spine,2004,1:90-94
[112]Le AX,Miclau T,Hu D,et al.Molecular aspects of healing in stabilized and non-stabilized fractures.J Orthop Res,2001,19:78-84
[113]Cho TJ,Gerstenfeld LC,Einhom TA.Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing.J Bone Miner Res,2002,17:513-520.
[114]Bertone AL,Pittman DD,Bouxsein ML,et al.Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model.J Orthop Res,2004,22:1261-1270
[115]Simic P,Culej JB,Orlic I,et al.Systemically administered bone morphogenetic protein-6restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption.J Biol Chem,2006,281:25509-25521
[116]Simic P,Buljan-Culej J,Orlic I,et al.BMP-6 restores bone in osteoporotic aged rats and,unlike estradiol and PTH,restores trabecular bone in ovariectomized BMP-6 knockout mice.J Bone Miner Res,2005,20:S8
[117]Xu WP,Shiba H,Mizuno N,et al.Effect of bone morphogenetic proteins-4,-5 and -6 on DNA synthesis and expression of bone-related proteins in cultured human periodontal ligament cells.Cell Biol Int,2004,28:675-682
[118]Huang KK,Shen C,Chiang CY,et al.Effects of bone morphogenetic protein-6 on periodontal wound healing in a fenestration defect of rats.J Periodontal Res,2005,40:1-10
[119]Bobacz K,Gruber R,Soleiman A,et al.Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro.Arthritis Rheum,2003,48:2501-2508
[120]Estes BT,Wu AW,Guilak F.Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6.Arthritis Rheum,2006,54:1222-1232
[121]Ren R,Charles PC,Zhang C,et al.Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses.Blood,2007,109:2847-2853
[122]Bursztyn M,Gross ML,Goltser-Dubner T,et al.Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats:evidence of subtle renal damage.Hypertension,2006,48:717-723
[123]Nguyen TQ,Chon H,van Nieuwenhoven FA,et al.Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6:a novel clue to adverse tissue remodelling? Diabetologia,2006,49:1039-1048
[124]Misawa S,Kumagai I.Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.Biopolymers,1999,51:297-307
[125]Schultz CP.Illuminating folding intermediates.Nat Struct Biol,2000,7:7-10
[126]Cemazar M,Zahariev S,Lopez JJ,et al.Oxidative folding intermediates with normative disulfide bridges between adjacent cysteine residues.Proc Natl Acad Sci USA,2003,100:5754-5759
[127]Chang JY,Li L,Lai PH,et al.A major kinetic trap for the oxidative folding of human epidermal growth factor.J Biol Chem,2001,276:4845-4852
[128]Rattenholl A,Lilie H,Grossmarm A,et al.The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies.Eur J Biochem,2001,268:3296-3303
[129]Lee GH,Cooney D,Middelberg AP,et al.The economics of inclusion body processing.Bioprocess Biosyst Eng,2006,29:73-90
[130]Vallejo LF,Rinas U.Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins.Microb Cell Fact,2004,3:1-12
[131]Middelberg AP.Preparative protein refolding.Trends Biotechnol,2002,20:437-443
[132]Li M,Su ZG,Janson JC.In vitro protein refolding by chromatographic procedures.Protein Expr Purif,2004,33:1-10
[133]Rudolph R,Lilie H.In vitro folding of inclusion body proteins.FASEB J,1996,10:49-56
[134]胡显文,陈惠鹏,汤仲明等。生物制药的现状与未来(二)发展趋势与希望。中国生物工程杂志,2005,25:86-93
[135]Florian M Wurm Production of recombinant protein therapeutics in cultivated mammalian cells.Nature Biotechnol,2004,22:1393-1398
[136]Makrides SC.Components of vectors for gene transfer and expression in mammalian cells.Protein Expr Purif,1999,17:183-202
[137]Kim JD,Yoon Y,Hwang HY,et al.Efficient selection of stable chinese hamster ovary (CHO) cell lines for expression of recombinant proteins by using human interferon beta SAR element.Biotechnol Prog.2005,21:933-937
[138]Kito M,Itami S,Fukano Y,et al.Construction of engineered CHO strains for high-level production of recombinant proteins.Appl Microbiol Biotechnol,2002,60:442-448
[139]Ramezani A,Hawley TS,Hawley RG.Performance-and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator.Blood,2003,101:4717-4724
[140]Lindenbaum M,Perkins E,Csonka E,et al.A mammalian artificial chromosome engineering system(ACE System) applicable to biopharmaceutical protein production,transgenesis and gene-based cell therapy.Nucleic Acids Res,2004,32:e172
[141]Jun SC,Kim MS,Baik JY,et al.Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reduetase-mediated gene amplification.Appl Microbiol Biotechnol,2005,69:162-169
[142]Barnes LM,Bentley CM,Dickson AJ.Characterization of the stability of recombinant protein production in the GS-NS0 expression system.Biotechnol Bioeng,2001,73:261-270
[143]Xie L,Wang DI.Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies.Biotechnol Bioeng,2006,95:270-284
[144]Chun C,Heineken K,Szeto D,et al.Application of factorial design to accelerate identification of CHO growth factor requirements.Biotechnol Prog,2003,19:52-57
[145]Hayduk EJ,Lee KH.Cytochalasin D can improve heterologous protein productivity in adherent Chinese hamster ovary cells.Biotechnol Bioeng,2005,90:354-364.
[146]Dinnis DM,James DC.Engineering mammalian cell factories for improved recombinant monoclonal antibody production:lessons from nature? Biotechnol Bioeng,2005,91:180-189
[147]Stansfield SH,Allen EE,Dinnis DM,et al.Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.Biotechnol Bioeng,2007,97:410-424
[148]Geisse S,Henke M.Large-scale transient transfection of mammalian cells:a newly emerging attractive option for recombinant protein production J Street Funct Genomics,2005,6:165-170
[149]Cerletti.Process for the production biologically active dimeric protein.United States Patent 6,057,430
[150]Long S,Truong L,Bennett K,et al.Expression,purification,and renaturation of bone morphogenetic protein-2 from Escherichia coli.Protein Expr Purif.2006,46:374-378
[151]Honda J,Andou H,Marmen T,et al.Direct refolding of recombinant human growth differentiation factor 5 for large-scale production process.J Biosci Bioeng,2000,89:582-589
[152]Ejima.Method of refolding human activin A.United States Patent 6,084,076
[153]Jin HJ,Dunn MA,Borthakur D,et al.Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli.Protein Expr Purif,2004,35:1-10
[154]Hoppe J,Weich HA,Eichner W,et al.Preparation of biologically active platelet-derived growth factor isoforms AA and AB.Preferential formation of AB heterodimers Eur J Biochem,1990,187:207-214
[155]雷荣悦,乔玉环,闫继东等。重组人BMP6在大肠杆菌中可溶表达、纯化及活性分析。生物工程学报,2008,24:452-459
[156]Patra AK,Mukhopadhyay R,Mukhija R,et al.Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.Protein Expr Purif,2000,18:182-192
[157]Saremba S,Nickel J,Seher A,et al.Type Ⅰ receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.FEBS J,2008,275:172-183
[158]Wolfman Refolding variant of bone morphogenetic protein-8.United States Patent 5,756,308
[159]Gray AM,Mason AJ.Requirement for activin A and transforming growth factor—beta 1pro-regions in homodimer assembly.Science,1990,247:1328-1330
[160]Zou Z,Sun PD.An improved recombinant mammalian cell expression system for human transforming growth factor-β2 and-β3 preparations Protein Expr Purif,2006,50:9-17
[161]Zou Z,Sun PD.Overexpression of human transforming growth factor-β1 using a recombinant CHO cell expression system.Protein Expr Purif,2004,37:265-272
[162]Omasa T.Gene amplification and its application in cell and tissue engineering.J Biosci Bioeng,2002,94:600-605
[163]Yoshikawa T,Nakanishi F,Ogura Y,et al.Amplified gene location in chromosomal DNA affected recombinant protein production and stability of amplified genes.Biotechnol Prog,2000,16:710-715
[164]Fann CH,Guirgis F,Chen G,et al.Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells.Biotechnol Bioeng,2000,69:204-212
[165]Swencki-Underwood B,Mills JK,Vennarini J,et al.Expression and characterization of a human BMP-7 variant with improved biochemical properties.Protein Expr Purif,2008,57:312-319
[166]Mathew S,Davies M,Lund R,et al.Function and effect of bone morphogenetic protein-7in kidney bone and the bone-vascular links in chronic kidney disease.Eur J Clin Invest,2006,36(Suppl 2):43-50
[167]Herzlinger D.Renal interstitial fibrosis:remembrance of things past? J Clin Invest,2002,110:305-306
[168]Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,molecular mechanism,and therapeutic intervention.J Am Soc Nephrol,2004,15:1-12
[169]Cheng J,Grande JP.Transforming growth factor-beta signal transduction and progressive renal disease.Exp Biol Med(Maywood),2002,227:943-956
[170]Rhyu DY,Yang Y,Ha H,et al.Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.J Am Soc Nephrol,2005,16:667-675
[171]Courtney AE,Maxwell AP.Heme oxygenase 1:does it have a role in renal cytoprotection?Am J Kidney Dis,2008,51:678-690
[172]Ryter SW,Morse D,Choi AM.Carbon monoxide and bilirubin:potential therapies for pulmonary vascular injury and disease Am J Respir Cell Mol Biol,2007,36:175-182
[173]Kie JH,Kapturczak MH,Traylor A,et al.Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis.J Am Soc Nephrol,2008,19:1681-1691
[174]Yang X,Lee PJ,Long L,et al.BMP4 induces HO-1 via a Smad-independent,p38MAPK-dependent pathway in pulmonary artery myocytes.Am J Respir Cell Mol Biol,2007,37:598-605
[175]Gould SE,Day M,Jones SS,et al.BMP-7 regulates chemokine,cytokine,and hemodynamic gene expression in proximal tubule cells.Kidney Int,2002,61:51-60
[176]Dennler S,Itoh S,Vivien D,et al.Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene.EMBO J,1998,17:3091-3100
[177]Hill-Kapturczak N,Sikorski E,Voakes C,et al.An internal enhancer regulates heme- and cadmium-mediated induction of human heine oxygenase-1.Am J Physiol Renal Physiol,2003,285:515-523
[178]Kr(o|¨)nke G,Kadl A,Ikonomu E,et al.Expression of heine oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.Arterioscler Thromb Vasc Biol,2007,27:1276-1282
[179]Lamouille S,Derynck R.Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.J Cell Biol,2007,178:437-451
[180]Zeisberg,M.Bone morphogenic protein-7 and the kidney:current concepts and open questions.Nephrol Dial Transplant,2006,21:568-573
[181]Ryan MJ,Johnson G,Kirk J,et al.HK-2:an immortalized proximal tubule epithelial cell line from normal adult human kidney.Kidney Int,1994,45:48-57
[182]Weight SC,Bell PR,Nicholson ML.Renal ischaemia-reperfusion injury.Br J Surg,1996,83:162-170
[183]Ha(y|¨) E,Lemonnier J,Fromigue O,et al.Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent;protein kinase C-dependent signaling pathway.J Biol Chem,2001,276:29028-29036
[184]De Petris L,Hruska KA,Chiechio S,et al.Bone morphogenetic protein-7 delays podocyte injury due to high glucose.Nephrol Dial Transplant,2007,22:3442-3450
[185]Yabe T,Samuels I,Schwartz JP.Bone morphogenetic proteins BMP-6 and BMF-7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons.J Neurosci Res,2002,68:161-168
[2] Senn, N. On the healing of aseptic bone cavities by implantation of antiseptic decalcified one. Am J Med Sci, 1889, 98:219-240
[3] Dimitriou R, Giannoudis PV. Discovery and development of BMPs. Injury, 2005, 36 Suppl 3:S28-33
[4] Lacroix P. Recent investigations on the growth of bone. Nature, 1945,156:576
[5] Sharrard WJ, Collins DH. The fate of human decalcified bone grafts. Proc Roy Soc Med, 1961,54:1101-1102
[6] Urist MR. Bone: formation by autoinduction. Science, 1965,150: 893-899
[7] Sampath TK, Reddi AH. Dissociative extraction and reconstitution of bone matrix components involved in local bone differentiation. Proc Natl Acad Sci USA, 1981, 78:7599-7603
[8] Sampath TK, Coughlin JE, Whetstone RM, et al. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J Biol Chem, 1990,265:13198-13205
[9] Johnson EE, Urist MR, Finerman GA. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin Orthop, 1992, 277:229-237
[10] Wozney JM, V. Rosen AJ, Celeste LM et al. Novel regulators of bone formation: molecular clones and activities. Science, 1988,242:1528-1534
[11] Celeste AJ, Iannazzi JA, Taylor RC. Identification of transforming growth factor β family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA, 1990, 87:9843-9847
[12] Urist MR, Iwata H, Ceccotti PL, et al. Bone morphogenesis in implants of insoluble bone gelatin. Proc Natl Acad Sci USA, 1973, 70:3511-3515
[13] Urist MR, Huo YK, Brownell AG, et al. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci USA, 1984, 81:371 -37
[14] Wang EA, Rosen V, Cordes P, et al. Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA, 1988, 85:9484-9488
[15] Luyten F, Cunningham NS, Ma S. Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem, 1989,265:13377-13380
[16] Ozkaynak EDC, Rueger EA, Drier C et al. OP-1 cDNA encodes an osteogenic protein in the TGF-β family.EMBO J,1990,9:2085-2093
[17]Wang EA,Rosen V,D'Alessandro JS et al.Recombinant human bone morphogenetic protein induces bone formation.Proc Natl Acad Sci,1990,87:2220-2224
[18]Hammonds RG,Schwall R,Dudley A.Bone-inducing activity of mature BMP-2B produced from a hybrid BMP-2A/2B precursor.Mol Endocrinol,1991,5:149-155
[19]K(u|¨)bler N.Herstellung und Biologic der bone morphogenetic proteins.Biomaterialien,2000,1:12-18
[20]Maruoka Y,Oida S,Iimura T et al.Production of functional human bone morphogenetic protein-2 using a baculovirus/Sf-9 insect cell system.Biochem Mol Biol Int,1995,35:957-963
[21]Hazama M,Aono A,Ueno N et al.Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system.Biochem Biophys Res Commun,1995,209:859-866
[22]Kubler NR,Reuther JF,Failer G et al.Inductive properties of recombinant human BMP-2produced in a bacterial expression system.Int J Oral Maxillofac Surg,1998,27:305-309
[23]Ruppert R,Hoffmann E,Sebald W.Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.Eur J Biochem,1996,237:295-302
[24]Vallejo LF,Brokelmann M,Marten S et al.Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.J Biotechnol,2002,94:185-194
[25]Vallejo LF,Rinas U.Optimized procedure for renaturation of recombinant human bone morphogenetic protein 2 at high concentration.Biotech Bioeng,2004,85:601-609
[26]Ten Dijke P,Yamashita H,Sampath TK,er al.Identification of type Ⅰ receptors for osteogenic protein-1 and bone morphogenetic protein-4.J Biol Chem,1994,269:16985-16988
[27]Rosenzweig BL,Imamura T,Okadome T,et al.Cloning and characterization of a human type Ⅱ receptor for bone morphogenetic proteins.Proc Natl Acad Sci USA,1995,92:7632-7636
[28]Lavery K,Swain P,Falb D,et al.BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells.J Biol Chem.2008 Jul 25;283(30):20948-58
[29]Miyazono K,Maeda S,Imamura T.BMP receptor signaling:Transcriptional targets,regulation of signals,and signaling cross-talk.Cytokine & Growth Factor Reviews,2005,16:251-263
[30]Zhang H,Bradley A.Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development.Development,1996,122:2977-2986
[31]Daluiski A,Engstrand T,Bahamonde ME,et al.Bone morphogenetic protein-3 is a negative regulator of bone density.Nat Genet,2001,27:84-88
[32]Winnier G,Blessing M,Labosky PA,et al.Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.Genes Dev,1995,9:2105-2116
[33]Lawson KA,Dunn NR,Roelen BA,et al.Bmp4 is required for the generation of primordial germ cells in the mouse embryo.Genes Dev,1999,13:424-436
[34]Kingsley DM,Bland AE,Grubber JM,et al.The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily.Cell,1992,71:399-410
[35]Solloway MJ,Dudley AT,Bikoff EK,et al.Mice lacking Bmp6 function.Dev Genet,1998,22:321-339
[36]Luo G,Hofmann C,Bronckers AL,et al.BMP-7 is an inducer of nephrogenesis,and is also required for eye development and skeletal patterning.Genes Dev,1995,9:2808-2820
[37]Zhao GQ,Liaw L,Hogan BL.Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis.Development,1998,125:1103-1112
[38]Zhao GQ,Deng K,Labosky PA,et al.The gene encoding bone morphogenetic protein 8B (BMP8B) is required for the initiation and maintenance of spermatogenesis in the mouse.Genes Dev,1996,10:1657-1669
[39]McPherron AC,Lawler AM,Lee SJ.Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11.Nat Genet,1999,22:260-264
[40]Maloul A,Rossmeier K,Mikic B,et al.Geometric and material contributions to whole bone structural behavior in GDF-7-deficient mice.Connect Tissue Res,2006,47:157-162
[41]Yan C,Wang P,DeMayo J,et al.Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.Mol Endocrinol,2001,15:854-866
[42]Storm EE,Huynh TV,Copeland NG,et al.Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily.Nature,1994,368:639-643
[43]McPherron AC,Lawler AM,Lee SJ.Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member.Nature,1997,387:83-90
[44]Dong J,Albertini DF,Nishimori K,et al.Growth differentiation factor-9 is required during early ovarian folliculogenesis.Nature,1996,383:531-535
[45]Ying Y,Zhao GQ.Cooperation of endoderm-derived BMP2 and extraembryonic ectoderm-derived BMP4 in primordial germ cell generation in the mouse.Dev Biol,2001,232:484-492
[46]Kugimiya F,Kawaguchi H,Kamekura S,et al.Involvement of endogenous bone morphogenetic protein 2 and 6 in bone formation.J Biol Chem,2005,280:35704-35711
[47]Katagiri T,Boorla S,Frendo JL,et al.Skeletal abnormalities in doubly heterozygous Bmp4and Bmp7 mice.Dev Genet,1998,22:340-348
[48]Solloway MJ,Robertson EJ.Early embryonic lethality in Bmp5/Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup.Development,1999,126:1753-1768
[49]Storm EE,Kingsley DM.Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein(BMP) family Development,1996,122:3969-3979
[50]Kim RY,Robertson EJ,Solloway MJ.Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart.Dev Biol,2001,235:449-466
[51]Zhao GQ,Chen YX,Liu XM,et al.Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis.Dev Biol,2001,240:212-222
[52]Ying Y,Liu XM,Marble A,et al.Requirement of Bmp8b for the Generation of Primordial Germ Cells in the Mouse.Mol.Endocrinol,2000,14:1053-1063
[53]Chen TL,Bates RL,Dudley A,et al.Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells:comparison with TGF-beta 1.J Bone Miner Res,1991,6:1387-1393
[54]Vukicevic S,Luyten FP,Reddi AH.Stimulation of the expression of osteogenic and chondrogenic phenotypes in vitro by osteogenin.Proc Natl Acad Sci USA,1989,86:8793-8797
[55]Chen P,Carrington JL,Hammonds RG,et al.Stimulation of chondrogenesis in limb bud mesoderm cells by recombinant human bone morphogenetic protein 2B(BMP-2B) and modulation by transforming growth factor beta 1 and beta 2.Exp Cell Res,1991,195:509-515
[56]Thies RS,Bauduy M,Ashton BA,et al.Recombinant human bone morphogenetic protein-2induces osteoblastic differentiation in W-20-17 stromal cells.Endocrinology,1992,130:1318-1324
[57]Wan M,Cao X.BMP signaling in skeletal development.Biochem Biophys Res Commun,2005,328:651-657
[58]Einhorn TA,Majeska RJ,Mohaideen A,et al.A single percutaneons injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair.J Bone Joint Surg Am,2003,85A:1425-1435
[59]Cook SD,Dalton JE,Tan EH,et al.In vivo evaluation of recombinant human osteogenic protein(rhOP-1) implants as a bone graft substitute for spinal fusions.Spine,1994,19:1655-1663
[60]Cook SD,Baffes G-C,Wolfe MW,et al.The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects.J Bone Joint Surg Am,1994,76:827-838
[61]Higuchi T,Kinoshita A,Takahashi K,et al.Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects.An experimental model of defect filling.J Periodontol,1999,70:1026-1031
[62]Cook SD,Patron LP,Salkeld SL,et al.Repair of articular cartilage defects with osteogenic protein-1(BMP-7) in dogs.J Bone Joint Surg Am,2003,85A(S3):116-123
[63]Simank HG,Manggold J,Sebald W,et al.Bone morphogenetic protein-2 and growth and differentiation factor-5 enhance the healing of necrotic bone in a sheep model.Growth Factors,2001,19:247-257.
[64]Wikesjo UM,Guglielmoni P,Promsudthi A,et al.Periodontal repair in dogs:effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment.J Clin Periodontol,1999,26:392-400
[65]Termaat MF,Den Boer FC,Bakker FC,et al.Bone morphogenetic proteins.Development and clinical efficacy in the treatment of fractures and bone defects.J Bone Joint Surg Am,2005,87:1367-1378
[66]Okubo Y,Bessho K,Fujimura K.et al.The time course study of osteoinduction by bone morphogenetic protein-2 via adenoviral vector.Life Sci,2001,70:325-336
[67]Groeneveld EHJ,Burger EH.Bone morphogenetic proteins in human bone regeneration.Eur J Endocrinol,2000,142:9-21
[68]Govender S,Csimma C,Genant HK,et al.BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group.Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures:a prospective,controlled,randomized study of four hundred and fifty patients.J Bone Joint Surg Am,2002,84A:2123-2134
[69]Geesink RGT,Hoefnagels NHM,Bulstra SK.Osteogenic activity of OP-1 bone morphogenetic protein(BMP-7) in a human fibular defect.J Bone Joint Surg Br,1999,81B:710-718
[70]Friedlaender GE,Perry CR,Cole JD,et al.Osteogenic protein-1(bone morphogenetic protein-7) in the treatment of tibial nonunions.J Bone Joint Surg Am,2001,83(S1):151-158
[71]Boden SD,Kang J,Sandhu H,et al.Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans:a prospective,randomized clinical pilot trial:2002 Volvo Award in clinical studies.Spine,2002,27:2662-2673
[72]Johnsson R,Stromqvist B,Aspenberg P.Randomized radiostereometric study comparing osteogenic protein-1(BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion:2002 Volvo Award in clinical studies.Spine,2002,27:2654-2661
[73]Zlotolow DA,Vaccaro AR,Salamon ML,et al.The role of human bone morphogenetic proteins in spinal fusion.J Am Acad Orthop Surg,2000,8:3-9
[74]Neuhaus H,Rosen V,Thies RS.Heart specific expression of mouse BMP-10 a novel member of the TGF-beta superfamily.Mech.Dev,1999,80:181-184
[75]Jiao K,Kulessa H,Tompkins K An essential role of Bmp4 in the atrioventricular septation of the mouse heart.Genes Dev.2003,17:2362-2367
[76]Behfar A,Zingman LV,Hodgson DM,et al.Stem cell differentiation requires a paracrine pathway in the heart.FASEB J,2002,16:1558-1566
[77]Sharma M,Kambadur R,Matthews KG,et al.Myostatin,a transforming growth factor-beta superfamily member,is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.J Cell Physiol,1999,180:1-9
[78]Kempf T,Eden M,Strelau J,et al.The transforming growth factor-{beta} superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury.Circ.Res.2006,98:351-360
[79]Humbert M,Trembath RC.Genetics of pulmonary hypertension:from bench to bedside.Eur Respir J,2002,20:741-749
[80]Cheng SL,Shao JS,Charlton-Kachigian N,et al.MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors.J Biol Chem,2003,278:45969-45977
[81]Swear A,Sane DC,Hutson SM,et al.Matrix Gla protein(MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats.J Thromb Haemost,2003,1:178-185
[82]Sorescu GP,Sykes M,Weiss D,et al.Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response.J Biol Chem,2003,278:31128-31135
[83]Davies MR,Lund RJ,Hruska KA.BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure.J Am Soc Nephrol,2003,14:1559-1567
[84]Chang CF,Lin SZ,Chiang YH,et al.Intravenous administration of bone morpbogenetic protein-7 after ischemia improves motor function in stroke rats.Stroke,2003,34:558-564
[85]Wang Y,Chang CF,Morales M,et al.Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats.Stroke,2001,32:2170-2178
[86]Dudley AT,Lyons KM,Robertson EJ.A requirement for bone morphogenetic protein-7during development of the mammalian kidney and eye.Genes Dev,1995,9:2795-2807
[87]Simic P,Vukicevic S.Bone morphogenetic proteins in development and homeostasis of kidney.Cytokine Growth Factor Rev.2005,16:299-308
[88]Zeisberg M,Hanai J,Sugimoto H,et al.BMP-7 counteracts TGF-betal-induced epithelial-tomesenchymal transition and reverses chronic renal injury.Nat Med,2003,9:964-968
[89]Miller AF,Harvey SA,Thies RS,et al.Bone morphogenetic protein-9.An autocrine/paracrine cytokine in the liver.J Biol Chem,2000,275:17937-17945
[90]Wang W,Yang Y,Meng Y,et al.GDF-3 is an adipogenic cytokine under high fat dietary condition.Biochem Biophys Res Commun,2004,321:1024-1031
[91]De Bosscher K,Hill CS,Nicolas FJ.Molecular and functional consequences of Smad4C-terminal missense mutations in colorectal tumour cells.Biochem J,2004,379:209-216
[92]Hanavadi S,Martin TA,Watkins G,et al.The role of growth differentiation factor-9(GDF-9)and its analog,GDF-gb/BMP-15,in human breast cancer.Ann Surg Oncol,2007,14:2159-2166
[93]Alarmo EL,Kuukasj(a|¨)rvi T,Karhu R,et al.comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7.Breast Cancer Res Treat,2007,103:239-246
[94]Schwalbe M,S(a|¨)ger J,Eggers R,et al.Differential expression and regulation of bone morphogenetic protein 7 in breast cancer.Int J Oncol,2003,23:89-95
[95]Buijs JT,Henriquez NV,van Overveld PG,et al.Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.Cancer Res,2007,67:8742-8751
[96]Alarmo EL,Korhonen T,Kuukasj(a|¨)rvi T,et al.Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.Ann Oncol,2008,19:308-314
[97]Lyons K,Graycar JL,Lee A,et al.Vgr-1,a mammalian gene related to Xenopus Vg-1,is a member of the transforming growth factor beta gene superfamily.Proc Natl Acad Sci USA,1989,86:4554-4558
[98]Ebisawa T,Tada K,Kitajima I,et al.Characterization of bone morphogenetic protein-6signaling pathways in osteoblast differentiation.J Cell Sci,1999,112:3519-3527.
[99]Sivertsen EA,Huse K,Hystad ME,et al.Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells.Eur J Immunol,2007,37:2937-2948
[100]Grimsrud CD,Romano PR,D'Souza M,et al.BMP-6 is an autocrine stimulator of chondrocyte differentiation.J Bone Miner Res,1999,14:475-482
[101]Boskey AL,Paschalis EP,Binderman I.BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures.J Cell Biochem,2002,84:509-519
[102]Kang Q,Sun MH,Cheng H,et al.Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery.Gene Ther,200411:1312-1320
[103]Li JZ,Li H,Sasaki T,et al.Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.Gene Ther,2003,10:1735-1743
[104]Cheng H,Jiang W,Phillips FM,et al.Osteogenic activity of the 14 types of human bone morphogenetic proteins(BMPs).J Bone Joint Surgery Am,2003,85:1544-1552
[105]Luu HH,Song WX,Luo X,et al.Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells.J Orthop Res,2007,25:665-677
[106]Peng Y,Kang Q,Cheng H,et al.Transcriptional characterization of bone morphogenetic proteins(BMPs)-mediated osteogenic signaling.J Cell Biochem,2003,90:1149-1165
[107]Zachos TA,Shields KM,Bertone AL.Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or-6.J Orthop Res,2006,24:1279-1291
[108]Friedman MS,Long MW,Hankenson KD.Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6.J Cell Biochem,2006,98:538-554
[109]Wutzl A,Brozek W,Lernbass I,et al.Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation.J Biomed Mater Res A,2006,77:75-83
[110]Valdes M,Moore DC,Palumbo M,et al.rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.Spine J,2007,7:318-325
[111]Laurent JJ,Webb KM,Beres EJ,et al.The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits.J Neurosurg Spine,2004,1:90-94
[112]Le AX,Miclau T,Hu D,et al.Molecular aspects of healing in stabilized and non-stabilized fractures.J Orthop Res,2001,19:78-84
[113]Cho TJ,Gerstenfeld LC,Einhom TA.Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing.J Bone Miner Res,2002,17:513-520.
[114]Bertone AL,Pittman DD,Bouxsein ML,et al.Adenoviral-mediated transfer of human BMP-6 gene accelerates healing in a rabbit ulnar osteotomy model.J Orthop Res,2004,22:1261-1270
[115]Simic P,Culej JB,Orlic I,et al.Systemically administered bone morphogenetic protein-6restores bone in aged ovariectomized rats by increasing bone formation and suppressing bone resorption.J Biol Chem,2006,281:25509-25521
[116]Simic P,Buljan-Culej J,Orlic I,et al.BMP-6 restores bone in osteoporotic aged rats and,unlike estradiol and PTH,restores trabecular bone in ovariectomized BMP-6 knockout mice.J Bone Miner Res,2005,20:S8
[117]Xu WP,Shiba H,Mizuno N,et al.Effect of bone morphogenetic proteins-4,-5 and -6 on DNA synthesis and expression of bone-related proteins in cultured human periodontal ligament cells.Cell Biol Int,2004,28:675-682
[118]Huang KK,Shen C,Chiang CY,et al.Effects of bone morphogenetic protein-6 on periodontal wound healing in a fenestration defect of rats.J Periodontal Res,2005,40:1-10
[119]Bobacz K,Gruber R,Soleiman A,et al.Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro.Arthritis Rheum,2003,48:2501-2508
[120]Estes BT,Wu AW,Guilak F.Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6.Arthritis Rheum,2006,54:1222-1232
[121]Ren R,Charles PC,Zhang C,et al.Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses.Blood,2007,109:2847-2853
[122]Bursztyn M,Gross ML,Goltser-Dubner T,et al.Adult hypertension in intrauterine growth-restricted offspring of hyperinsulinemic rats:evidence of subtle renal damage.Hypertension,2006,48:717-723
[123]Nguyen TQ,Chon H,van Nieuwenhoven FA,et al.Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6:a novel clue to adverse tissue remodelling? Diabetologia,2006,49:1039-1048
[124]Misawa S,Kumagai I.Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.Biopolymers,1999,51:297-307
[125]Schultz CP.Illuminating folding intermediates.Nat Struct Biol,2000,7:7-10
[126]Cemazar M,Zahariev S,Lopez JJ,et al.Oxidative folding intermediates with normative disulfide bridges between adjacent cysteine residues.Proc Natl Acad Sci USA,2003,100:5754-5759
[127]Chang JY,Li L,Lai PH,et al.A major kinetic trap for the oxidative folding of human epidermal growth factor.J Biol Chem,2001,276:4845-4852
[128]Rattenholl A,Lilie H,Grossmarm A,et al.The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies.Eur J Biochem,2001,268:3296-3303
[129]Lee GH,Cooney D,Middelberg AP,et al.The economics of inclusion body processing.Bioprocess Biosyst Eng,2006,29:73-90
[130]Vallejo LF,Rinas U.Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins.Microb Cell Fact,2004,3:1-12
[131]Middelberg AP.Preparative protein refolding.Trends Biotechnol,2002,20:437-443
[132]Li M,Su ZG,Janson JC.In vitro protein refolding by chromatographic procedures.Protein Expr Purif,2004,33:1-10
[133]Rudolph R,Lilie H.In vitro folding of inclusion body proteins.FASEB J,1996,10:49-56
[134]胡显文,陈惠鹏,汤仲明等。生物制药的现状与未来(二)发展趋势与希望。中国生物工程杂志,2005,25:86-93
[135]Florian M Wurm Production of recombinant protein therapeutics in cultivated mammalian cells.Nature Biotechnol,2004,22:1393-1398
[136]Makrides SC.Components of vectors for gene transfer and expression in mammalian cells.Protein Expr Purif,1999,17:183-202
[137]Kim JD,Yoon Y,Hwang HY,et al.Efficient selection of stable chinese hamster ovary (CHO) cell lines for expression of recombinant proteins by using human interferon beta SAR element.Biotechnol Prog.2005,21:933-937
[138]Kito M,Itami S,Fukano Y,et al.Construction of engineered CHO strains for high-level production of recombinant proteins.Appl Microbiol Biotechnol,2002,60:442-448
[139]Ramezani A,Hawley TS,Hawley RG.Performance-and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator.Blood,2003,101:4717-4724
[140]Lindenbaum M,Perkins E,Csonka E,et al.A mammalian artificial chromosome engineering system(ACE System) applicable to biopharmaceutical protein production,transgenesis and gene-based cell therapy.Nucleic Acids Res,2004,32:e172
[141]Jun SC,Kim MS,Baik JY,et al.Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reduetase-mediated gene amplification.Appl Microbiol Biotechnol,2005,69:162-169
[142]Barnes LM,Bentley CM,Dickson AJ.Characterization of the stability of recombinant protein production in the GS-NS0 expression system.Biotechnol Bioeng,2001,73:261-270
[143]Xie L,Wang DI.Fed-batch cultivation of animal cells using different medium design concepts and feeding strategies.Biotechnol Bioeng,2006,95:270-284
[144]Chun C,Heineken K,Szeto D,et al.Application of factorial design to accelerate identification of CHO growth factor requirements.Biotechnol Prog,2003,19:52-57
[145]Hayduk EJ,Lee KH.Cytochalasin D can improve heterologous protein productivity in adherent Chinese hamster ovary cells.Biotechnol Bioeng,2005,90:354-364.
[146]Dinnis DM,James DC.Engineering mammalian cell factories for improved recombinant monoclonal antibody production:lessons from nature? Biotechnol Bioeng,2005,91:180-189
[147]Stansfield SH,Allen EE,Dinnis DM,et al.Dynamic analysis of GS-NS0 cells producing a recombinant monoclonal antibody during fed-batch culture.Biotechnol Bioeng,2007,97:410-424
[148]Geisse S,Henke M.Large-scale transient transfection of mammalian cells:a newly emerging attractive option for recombinant protein production J Street Funct Genomics,2005,6:165-170
[149]Cerletti.Process for the production biologically active dimeric protein.United States Patent 6,057,430
[150]Long S,Truong L,Bennett K,et al.Expression,purification,and renaturation of bone morphogenetic protein-2 from Escherichia coli.Protein Expr Purif.2006,46:374-378
[151]Honda J,Andou H,Marmen T,et al.Direct refolding of recombinant human growth differentiation factor 5 for large-scale production process.J Biosci Bioeng,2000,89:582-589
[152]Ejima.Method of refolding human activin A.United States Patent 6,084,076
[153]Jin HJ,Dunn MA,Borthakur D,et al.Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli.Protein Expr Purif,2004,35:1-10
[154]Hoppe J,Weich HA,Eichner W,et al.Preparation of biologically active platelet-derived growth factor isoforms AA and AB.Preferential formation of AB heterodimers Eur J Biochem,1990,187:207-214
[155]雷荣悦,乔玉环,闫继东等。重组人BMP6在大肠杆菌中可溶表达、纯化及活性分析。生物工程学报,2008,24:452-459
[156]Patra AK,Mukhopadhyay R,Mukhija R,et al.Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli.Protein Expr Purif,2000,18:182-192
[157]Saremba S,Nickel J,Seher A,et al.Type Ⅰ receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.FEBS J,2008,275:172-183
[158]Wolfman Refolding variant of bone morphogenetic protein-8.United States Patent 5,756,308
[159]Gray AM,Mason AJ.Requirement for activin A and transforming growth factor—beta 1pro-regions in homodimer assembly.Science,1990,247:1328-1330
[160]Zou Z,Sun PD.An improved recombinant mammalian cell expression system for human transforming growth factor-β2 and-β3 preparations Protein Expr Purif,2006,50:9-17
[161]Zou Z,Sun PD.Overexpression of human transforming growth factor-β1 using a recombinant CHO cell expression system.Protein Expr Purif,2004,37:265-272
[162]Omasa T.Gene amplification and its application in cell and tissue engineering.J Biosci Bioeng,2002,94:600-605
[163]Yoshikawa T,Nakanishi F,Ogura Y,et al.Amplified gene location in chromosomal DNA affected recombinant protein production and stability of amplified genes.Biotechnol Prog,2000,16:710-715
[164]Fann CH,Guirgis F,Chen G,et al.Limitations to the amplification and stability of human tissue-type plasminogen activator expression by Chinese hamster ovary cells.Biotechnol Bioeng,2000,69:204-212
[165]Swencki-Underwood B,Mills JK,Vennarini J,et al.Expression and characterization of a human BMP-7 variant with improved biochemical properties.Protein Expr Purif,2008,57:312-319
[166]Mathew S,Davies M,Lund R,et al.Function and effect of bone morphogenetic protein-7in kidney bone and the bone-vascular links in chronic kidney disease.Eur J Clin Invest,2006,36(Suppl 2):43-50
[167]Herzlinger D.Renal interstitial fibrosis:remembrance of things past? J Clin Invest,2002,110:305-306
[168]Liu Y.Epithelial to mesenchymal transition in renal fibrogenesis:pathologic significance,molecular mechanism,and therapeutic intervention.J Am Soc Nephrol,2004,15:1-12
[169]Cheng J,Grande JP.Transforming growth factor-beta signal transduction and progressive renal disease.Exp Biol Med(Maywood),2002,227:943-956
[170]Rhyu DY,Yang Y,Ha H,et al.Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.J Am Soc Nephrol,2005,16:667-675
[171]Courtney AE,Maxwell AP.Heme oxygenase 1:does it have a role in renal cytoprotection?Am J Kidney Dis,2008,51:678-690
[172]Ryter SW,Morse D,Choi AM.Carbon monoxide and bilirubin:potential therapies for pulmonary vascular injury and disease Am J Respir Cell Mol Biol,2007,36:175-182
[173]Kie JH,Kapturczak MH,Traylor A,et al.Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis.J Am Soc Nephrol,2008,19:1681-1691
[174]Yang X,Lee PJ,Long L,et al.BMP4 induces HO-1 via a Smad-independent,p38MAPK-dependent pathway in pulmonary artery myocytes.Am J Respir Cell Mol Biol,2007,37:598-605
[175]Gould SE,Day M,Jones SS,et al.BMP-7 regulates chemokine,cytokine,and hemodynamic gene expression in proximal tubule cells.Kidney Int,2002,61:51-60
[176]Dennler S,Itoh S,Vivien D,et al.Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1gene.EMBO J,1998,17:3091-3100
[177]Hill-Kapturczak N,Sikorski E,Voakes C,et al.An internal enhancer regulates heme- and cadmium-mediated induction of human heine oxygenase-1.Am J Physiol Renal Physiol,2003,285:515-523
[178]Kr(o|¨)nke G,Kadl A,Ikonomu E,et al.Expression of heine oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.Arterioscler Thromb Vasc Biol,2007,27:1276-1282
[179]Lamouille S,Derynck R.Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway.J Cell Biol,2007,178:437-451
[180]Zeisberg,M.Bone morphogenic protein-7 and the kidney:current concepts and open questions.Nephrol Dial Transplant,2006,21:568-573
[181]Ryan MJ,Johnson G,Kirk J,et al.HK-2:an immortalized proximal tubule epithelial cell line from normal adult human kidney.Kidney Int,1994,45:48-57
[182]Weight SC,Bell PR,Nicholson ML.Renal ischaemia-reperfusion injury.Br J Surg,1996,83:162-170
[183]Ha(y|¨) E,Lemonnier J,Fromigue O,et al.Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent;protein kinase C-dependent signaling pathway.J Biol Chem,2001,276:29028-29036
[184]De Petris L,Hruska KA,Chiechio S,et al.Bone morphogenetic protein-7 delays podocyte injury due to high glucose.Nephrol Dial Transplant,2007,22:3442-3450
[185]Yabe T,Samuels I,Schwartz JP.Bone morphogenetic proteins BMP-6 and BMF-7 have differential effects on survival and neurite outgrowth of cerebellar granule cell neurons.J Neurosci Res,2002,68:161-168
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |